Please wait, loading...
THE ADVISORY COMMITTEE ON THE MISUSE OF DRUGS (ACMD) PUBLISHED ITS CONCLUSIONS INTO THE APPROPRIATE MAXIMUM CONTROLLED CANNABINOID LEVEL WITHIN CANNABIDIOL (CBD) “WELLNESS” PRODUCTS
Food Standard Agency Chief Executive's Report to the Board (8TH DECEMBER 2021).
RE: Food Standard Authority (FSA) Novel Food applications for cannabidiol; Implications for replicate toxicity testing in animals
There is a prescribed process which must be followed prior to any change in laws which relate to controlled substances in the United Kingdom.
With today’s announcement we would suggest that the FSA have significantly moved the goalposts after the start of the match. The question is, who would ever have predicted it?
Until today there were two options following the submission of a Novel Food application: Validated or Unvalidated. It now appears as though there is a third: Unvalidated, but heading in the right direction.
As we approach the deadline for submission in order to achieve the benefit of the UK Food Standard Agency’s position on Cannabidiol, the industry in Northern Ireland is dealt a body- blow which many will not be aware of.
We return briefly to a fundamental topic which we have written about before – in both 2019 and 2020: If THC is not permitted in products, to what level of precision is the product to be examined to establish the THC level?
In May we published an analysis of the Judgement of Advocate General Tanchev in respect of the Kanavape case, “Can the movement of CBD within the European Member States be prohibited it if is derived from prohibited elements of the plant?”. We observed that there was “good” and “bad” in the provisional Opinion.
The FSA refutes claims made by a prominent self-styled trade organisation that it has changed its toxicology policy.